Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Routine beta-blockade in vascular surgery.

Francesco Torella1, Linda de Cossart, Sameh K Dimitri

  • 1Department of Surgery, Countess of Chester Hospital, Liverpool Road, Chester CH2 1UL, UK. fcmtdr@aol.com

Cardiovascular Surgery (London, England)
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling point defect populations in AlGaN deep UV LEDs.

Nanotechnology·2026
Same author

Abdominal Aortic Aneurysm in Women and Men: A Systematic Review of Sex-Specific Outcomes in the United Kingdom.

Annals of vascular surgery·2025
Same author

Micromechanical heterogeneity in abdominal aortic aneurysms is associated with rupture risk.

Acta biomaterialia·2025
Same author

Retroperitoneal vs transperitoneal approach for nonruptured open conversion after endovascular aneurysm repair.

Journal of vascular surgery·2024
Same author

An Expert Delphi Consensus on Risk Factors for Adverse Events After Endovascular Aortic Aneurysm Repair: Tier 1 Study From the International RIsk Stratification in EVAR (IRIS-EVAR) Working Group.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2024
Same author

Simultaneous mapping of cathodoluminescence spectra and backscatter diffraction patterns in a scanning electron microscope.

Nanotechnology·2024

Routine beta-blockade significantly reduced cardiac complications and deaths in patients undergoing major vascular surgery. This perioperative treatment with atenolol proved safe and effective for preventing adverse cardiac events.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Pharmacology

Background:

  • Atherosclerotic arterial disease poses significant risks for cardiac complications during major vascular surgery.
  • Preventive strategies for perioperative cardiac events in high-risk surgical patients are crucial.

Purpose of the Study:

  • To evaluate the safety and efficacy of routine beta-blockade for preventing cardiac complications in patients undergoing major vascular surgery.
  • To assess the impact of perioperative atenolol on cardiac morbidity and mortality.

Main Methods:

  • A prospective study comparing outcomes before and after the introduction of routine perioperative beta-blockade (atenolol).
  • Patient cohorts undergoing major vascular surgery or amputation for atherosclerotic arterial disease were analyzed.

Related Experiment Videos

  • Cardiac complications and mortality were the primary outcome measures.

    • Main Results:

    • Cardiac complications decreased from 10 to 1 (P=0.01) after implementing routine beta-blockade.
    • Deaths reduced from eight to two (P=0.052) in the beta-blockade group.
    • Multivariate analysis identified beta-blocker treatment as the sole significant factor reducing cardiac morbidity (OR=0.12; P=0.014).

    Conclusions:

    • Routine perioperative beta-blockade with atenolol is safe and effective in reducing cardiac complications after major vascular surgery.
    • Beta-blockade significantly lowers cardiac morbidity in patients with atherosclerotic arterial disease undergoing major vascular procedures.
    • The study supports the use of perioperative beta-blockers as a key strategy in managing high-risk surgical patients.